Cita APA

Fukano, R., Mori, T., Sekimizu, M., Choi, I., Kada, A., Saito, A. M., . . . Nagai, H. (2020). Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial. Cancer Sci.

Citación estilo Chicago

Fukano, Reiji, et al. "Alectinib for Relapsed or Refractory Anaplastic Lymphoma Kinase‐positive Anaplastic Large Cell Lymphoma: An Open‐label Phase II Trial." Cancer Sci 2020.

Cita MLA

Fukano, Reiji, et al. "Alectinib for Relapsed or Refractory Anaplastic Lymphoma Kinase‐positive Anaplastic Large Cell Lymphoma: An Open‐label Phase II Trial." Cancer Sci 2020.